Showing results (51-60 of 168) with videos related to
Sort By:
Pageof 17
Arteriosclerosis, Thrombosis, and Vascular Biology|March 5, 2003
Human serum paraoxonase 1 decreases macrophage cholesterol biosynthesis: possible role for its phospholipase-A2-like activity and lysophosphatidylcholine formationOrit Rozenberg, Diana M Shih, Michael AviramAtherosclerosis|May 4, 2013
Paraoxonase1 (PON1) reduces insulin resistance in mice fed a high-fat diet, and promotes GLUT4 overexpression in myocytes, via the IRS-1/Akt pathwayMarie Koren-Gluzer, Michael Aviram, Tony HayekLife Sciences|April 27, 2016
Aqueous or lipid components of atherosclerotic lesion increase macrophage oxidation and lipid accumulationNiroz Abu-Saleh, Michael Aviram, Tony HayekJournal of Cardiovascular Pharmacology|June 20, 2002
Valsartan therapy has additive anti-oxidative effect to that of fluvastatin therapy against low-density lipoprotein oxidation: studies in hypercholesterolemic and hypertensive patientsOsamah Hussein, Julia Shneider, Mira Rosenblat, et al.Biochemical and Biophysical Research Communications|February 1, 2002
Angiotensin II reduces macrophage cholesterol efflux: a role for the AT-1 receptor but not for the ABC1 transporterMarielle Kaplan, Michael Aviram, Carlos Knopf, et al.Free Radical Biology & Medicine|June 19, 2004
Cell-induced copper ion-mediated low density lipoprotein oxidation increases during in vivo monocyte-to-macrophage differentiationBianca Fuhrman, Maayan Shiner, Nina Volkova, et al.Biofactors (Oxford, England)|October 11, 2012
Triglyceride accumulation in macrophages upregulates paraoxonase 2 (PON2) expression via ROS-mediated JNK/c-Jun signaling pathway activationMira Rosenblat, Nina Volkova, Nicole Paland, et al.Journal of Agricultural and Food Chemistry|March 2, 2006
Pomegranate byproduct administration to apolipoprotein e-deficient mice attenuates atherosclerosis development as a result of decreased macrophage oxidative stress and reduced cellular uptake of oxidized low-density lipoproteinMira Rosenblat, Nina Volkova, Raymond Coleman, et al.Bioorganic & Medicinal Chemistry|June 24, 2008
Characterization of the PON1 active site using modeling simulation, in relation to PON1 lactonase activityHagai Tavori, Soliman Khatib, Michael Aviram, et al.Atherosclerosis|June 26, 2007
Anti-oxidant and anti-atherogenic properties of liposomal glutathione: studies in vitro, and in the atherosclerotic apolipoprotein E-deficient miceMira Rosenblat, Nina Volkova, Raymond Coleman, et al.Pageof 17